[Evaluation of recombinant retrovirus and adenovirus for gene transfer to normal and pathologic intestinal tissue].
Intestinal tract is an attractive target for gene therapy. A number of diseases could benefit from gene transfer into this organ and in particular inflammatory diseases such as Crohn's disease. In the present report, we have evaluated the efficiency of retroviral and adenoviral recombinant vectors for transferring a marker gene (beta galactosidase from E. Coli) in two parts of the intestinal tract: the small bowel and the left part of the colon. Retroviruses were inefficient for the transfer of the marker gene in these two sites either in normal conditions or after induction of inflammation by treatment with acetic acid or trinitrobenzene. Conversely, beta galactosidase positive cells were found in small bowel as well as colon following gene transfer with adenoviral vectors. Moreover the location of the positive cells in the intestinal wall was dependent upon the route of injection of the adenoviral vectors (transparietal, endoluminal or intramural).
Laine
F
F
Service de Gastroentérologie, CHU Pontchaillou Rennes.
Blouin
V
V
Ferry
N
N
D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D002478:Cells, Cultured; D004926:Escherichia coli; D005069:Evaluation Studies as Topic; D005822:Genetic Vectors; D007763:Lac Operon; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D011995:Recombination, Genetic; D012016:Reference Values; D012190:Retroviridae / Q000235:genetics*; D001616:beta-Galactosidase / Q000235:genetics
D001616:beta-Galactosidase